These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14483691)

  • 1. Complement fixing antibodies in guinea pigs after inoculation of poliovirus antigens.
    PAPAPANAGIOTOU J; VON MAGNUS H
    Acta Pathol Microbiol Scand; 1962; 54():99-106. PubMed ID: 14483691
    [No Abstract]   [Full Text] [Related]  

  • 2. [The microflocculation reaction, on slides using the agar double diffusion technic, between poliomyelitis antigens and antibodies. II. Comparative study of the neutralizing, complement-fixing and flocculation antibodies].
    PACCAUD MF; PONGRATZ E; SCHLAEPFER J
    Arch Gesamte Virusforsch; 1960; 10():351-60. PubMed ID: 13731895
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the complement-fixing antigens of poliomyelitis. III. Intracellular development of antigen.
    HINUMA Y; HUMMELER K
    J Immunol; 1961 Oct; 87():367-75. PubMed ID: 13907581
    [No Abstract]   [Full Text] [Related]  

  • 4. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. III. Comparison of the potency of complement fixing antigens derived from different strains of poliomyelitis virus.
    SCHMIDT NJ; LENNETTE EH; DENNIS J; HAGENS SJ
    J Immunol; 1960 Jul; 85():67-71. PubMed ID: 14443080
    [No Abstract]   [Full Text] [Related]  

  • 5. Appearance of soluble and cross-reactive complement-fixing antigens on treatment of poliovirus with formalin.
    BLACK FL; MELNICK JL
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):353-5. PubMed ID: 13254758
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the preparation of complement fixing polio antigens.
    PAPAPANAGIOTOU J
    Acta Pathol Microbiol Scand; 1961; 53():280-92. PubMed ID: 14483692
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of complement-fixing antigens by types 1 and 2 poliomyelitis-infected suckling mouse brains.
    SELZER G
    J Hyg (Lond); 1959 Sep; 57(3):321-5. PubMed ID: 14444802
    [No Abstract]   [Full Text] [Related]  

  • 8. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 9. A batch-type concentration and purification procedure for poliovirus complement fixing antigen.
    SUGGS MT; CASEY HL; SLIGH DD; FODOR AR; McLIMANS WF
    J Bacteriol; 1961 Nov; 82(5):789-91. PubMed ID: 13918198
    [No Abstract]   [Full Text] [Related]  

  • 10. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. II. The sensitivity and specificity of antigens derived from various strains.
    SCHMIDT N; LENNETTE EH; HAGENS SJ; DENNIS J
    J Immunol; 1960 Feb; 84():160-70. PubMed ID: 14443079
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of noninfectious complement-fixing poliovirus particles in HeLa cells treated with proflavine.
    LEDINKO N
    Virology; 1958 Oct; 6(2):512-24. PubMed ID: 13593187
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement-fixing antibodies produced in guinea pigs immunized with purified N and H antigens of poliovirus.
    Katagiri S; Hinuma Y
    Tohoku J Exp Med; 1966 Feb; 88(2):153-60. PubMed ID: 4289079
    [No Abstract]   [Full Text] [Related]  

  • 14. Complementfixing antigens of living and inactivated poliovirus. I. Complement-fixing antibody response of laboratory animals to poliovirus.
    HARE JD; WARREN J
    Am J Hyg; 1958 May; 67(3):350-66. PubMed ID: 13533408
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological strain specificity within type 1 poliovirus.
    GARD S
    Bull World Health Organ; 1960; 22(3-4):235-42. PubMed ID: 13826481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-fixing antigens of live and inactivated poliovirus. III. Evaluation of a sensitive quantitative procedure for complement fixation.
    HARE JD; WARREN J
    Am J Hyg; 1958 Nov; 68(3):312-21. PubMed ID: 13594931
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of specific complement-fixing antigens from the three prototypes of poliomyelitis viruses.
    POLLARD M; HSIANG CM; SHARP GR
    Proc Soc Exp Biol Med; 1952 Jan; 79(1):48-50. PubMed ID: 14892034
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fate of poliomyelitis virus type 2 after parenteral inoculation in guinea pigs and serological responses].
    FLACCOMIO R; ODDO FG
    Riv Ist Sieroter Ital; 1956; 31(3):174-7. PubMed ID: 13380263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on epidemiology and immunology of poliomyelitis conducted by tissue culture methods].
    MELNICK JL
    Minerva Med; 1954 May; 45(41):1454-61. PubMed ID: 13193666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.